BioAtla (BCAB) Enterprise Value (2020 - 2026)
BioAtla's Enterprise Value came in at $5.34 million for Q2 2026, down 99.5% from $1.14 billion a year earlier and down 53.1% from the prior quarter.
Powered by 
Analysis
BioAtla (BCAB) Enterprise Value (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, BioAtla reported Enterprise Value of -$12.06 million; for FY2025, it was $1.8 billion, up 7.6% from FY2024.
- Enterprise Value carries a five-year compound annual growth rate of -57.8% (FY2020 to FY2025).
- Going back by year, Enterprise Value was $1.67 billion in FY2024 (-71.3%), $5.8 billion in FY2023 (-69.3%), $18.9 billion in FY2022 (-45.8%) and $34.89 billion in FY2021 (-73.8%).
- The Q2 2026 figure represents the lowest quarterly Enterprise Value in data going back to Q4 2020.
- Year-over-year, Enterprise Value increased in two of the last eight quarters, with an average decline of 57.5%.
- The fastest year-over-year change in Enterprise Value over five years came in Q2 2023 (growth of 42.1%), and the weakest in Q2 2026 (a decline of 99.5%).
- Business Quant data shows BCAB's Enterprise Value at $11.4 million (Q1 2026), $1.8 billion (Q4 2025) and $2.01 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | BioAtla | 2.49 Mn | 2.49 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.34 Mn |
| Mar 31, 2026 | 11.40 Mn |
| Dec 31, 2025 | 1.80 Bn |
| Sep 30, 2025 | 2.01 Bn |
| Jun 30, 2025 | 1.14 Bn |
| Mar 31, 2025 | 980.90 Mn |
| Dec 31, 2024 | 1.67 Bn |
| Sep 30, 2024 | 4.20 Bn |
| Jun 30, 2024 | 3.25 Bn |
| Mar 31, 2024 | 8.19 Bn |
| Dec 31, 2023 | 5.80 Bn |
| Sep 30, 2023 | 3.93 Bn |
| Jun 30, 2023 | 7.00 Bn |
| Mar 31, 2023 | 6.19 Bn |
| Dec 31, 2022 | 18.90 Bn |
| Sep 30, 2022 | 13.82 Bn |
| Jun 30, 2022 | 4.93 Bn |
| Mar 31, 2022 | 8.75 Bn |
| Dec 31, 2021 | 34.89 Bn |
| Sep 30, 2021 | 51.53 Bn |
API Access
BioAtla Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=BCAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "BCAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=BCAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();